Clinical Trial Update: IL-1 Signal Inhibition in Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an IL-1 signaling inhibitor for alcoholic hepatitis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• IL-1 signal inhibitor

Snippet

Sponsor: Imperial College London | Conditions: Alcoholic Hepatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-03-11